Adipocytes with increased hexosamine flux exhibit insulin resistance, increased glucose uptake, and increased synthesis and storage of lipid

American Journal of Physiology - Endocrinology and Metabolism

Volumn 288, Issue 5 51-5, 2005, Pages

  McClain, Donald A ^a,b   Hazel, Mark ^b   Parker, Glendon ^b   Cooksey, Robert C ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Adipocyte; Hexosamine; Insulin resistance

Indexed keywords

DEOXYGLUCOSE; FRUCTOKINASE; GLUCOSE; GLUCOSE TRANSPORTER 4; HEXOSAMINE; INSULIN; LIPID;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HYPERCHOLESTEROLEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIPID STORAGE; LIPOGENESIS; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TISSUE SPECIFICITY; TRANSGENIC MOUSE;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; CELL PROLIFERATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; GLUTAMINE-FRUCTOSE-6-PHOSPHATE TRANSAMINASE (ISOMERIZING); HEXOSAMINES; INSULIN RESISTANCE; LIPID METABOLISM; MICE; MICE, TRANSGENIC; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; ORGAN SIZE;

EID: 17444381142     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00549.2004     Document Type: Article

References (45)

1. Boehmelt G, Wakeham A, Elia A, Sasaki T, Plyte S, Potter J, Yang Y, Tsang E, Ruland J, Iscove NN, Dennis JW, and Mak TW. Decreased UDP-GlcNAc levels abrogate proliferation control in EMeg32-deficient cells. EMBO J 19: 5092-5104, 2000.
2. Ciaraldi TP, Kolterman OG, and Olefsky JM. Mechanism of the postreceptor defect in insulin action in human obesity. Decrease in glucose transport system activity. J Clin Invest 68: 875-880, 1981.
3. Comer FI and Hart GW. O-Glycosylation of nuclear and cytosolic proteins. Dynamic interplay between O-GlcNAc and O-phosphate. J Biol Chem 275: 29179-29182, 2000.
4. Cooksey RC, Hebert LF Jr, Zhu JH, Wofford P, Garvey WT, and McClain DA. Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine:fructose-6-phosphate amido-transferase: decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione. Endocrinology 140: 1151-1157, 1999.
5. Cushman SW and Salans LB. Determinations of adipose cell size and number in suspensions of isolated rat and human adipose cells. J Lipid Res 19: 269-273, 1978.
6. Daniels MC, Ciaraldi TP, Nikoulina S, Henry RR, and McClain DA. Glutamine:fructose-6-phosphate amidotransferase activity in cultured human skeletal muscle cells: relationship to glucose disposal rate in control and non-insulin-dependent diabetes mellitus subjects and regulation by glucose and insulin. J Clin Invest 97: 1235-1241, 1996.
7. Garvey WT, Huecksteadt TP, and Birnbaum MJ. Pretranslational suppression of an insulin-responsive glucose transporter in rats with diabetes mellitus. Science 245: 60-63, 1989.
8. Garvey WT, Maianu L, Huecksteadt TP, Birnbaum MJ, Molina JM, and Ciaraldi TP. Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity. J Clin Invest 87: 1072-1081, 1991.
9. Graves RA, Tontonoz P, Platt KA, Ross SR, and Spiegelman BM. Identification of a fat cell enhancer: analysis of requirements for adipose tissue-specific gene expression. J Cell Biochem 49: 219-224, 1992.
10. Hazel M, Cooksey KC, Jones D, Parker G, Neidigh JL, Witherbee B, Gulve EA, and McClain DA. Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance. Endocrinology 145: 2118-2128, 2004.
11. Hebert LF Jr, Daniels MC, Zhou J, Crook ED, Turner RL, Simmons ST, Neidigh JL, Zhu JS, Baron AD, and McClain DA. Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J Clin Invest 98: 930-936, 1996.
12. Hresko RC, Heimberg H, Chi MM, and Mueckler M. Glucosamine-induced insulin resistance in 3T3-L1 adipocytes is caused by depletion of intracellular ATP. J Biol Chem 273: 20658-20668, 1998.
13. Kahn BB. Dietary regulation of glucose transporter gene expression: tissue specific effects in adipose cells and muscle. J Nutr 124: 1289S-1295S, 1994.
14. Kahn BB. Lilly lecture 1995. Glucose transport: pivotal step in insulin action. Diabetes 45: 1644-1654, 1996.
15. Lekanne Deprez RH, Fijnvandraat AC, Ruijter JM, and Moorman AF. Sensitivity and accuracy of quantitative real-time polymerase chain reaction using SYBR green I depends on cDNA synthesis conditions. Anal Biochem 307: 63-69, 2002.
16. Li J, Houseknecht KL, Stenbit AE, Katz EB, and Charron MJ. Reduced glucose uptake precedes insulin signaling defects in adipocytes from heterozygous GLUT4 knockout mice. FASEB J 14: 1117-1125, 2000.
17. Lubas WA and Hanover JA. Functional expression of O-linked GlcNAc transferase. Domain structure and-substrate specificity. J Biol Chem 275: 10983-10988, 2000.
18. Marchesini S and Poirier Y. Futile cycling of intermediates of fatty acid biosynthesis toward peroxisomal beta-oxidation in Saccharomyces cerevisiae. J Biol Chem 278: 32596-32601, 2003.
19. Marshall S, Bacote V, and Traxinger RR. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266: 4706-4712, 1991.
20. McClain DA and Crook ED. Hexosamines and insulin resistance. Diabetes 45: 1003-1009, 1996.
21. McClain DA, Lubas WA, Cooksey RC, Hazel M, Parker GJ, Love DC, and Hanover JA. Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc Natl Acad Sci USA 99: 10695-10699, 2002.
22. McClain DA, Paterson AJ, Roos MD, Wei X, and Kudlow JE. Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc Natl Acad Sci USA 89: 8150-8154, 1992.
23. McGarry JD, Kuwajima M, Newgard CB, Foster DW, and Katz J. From dietary glucose to liver glycogen: the full circle round. Annu Rev Nutr 7: 51-73, 1987.
24. Misso ML, Murata Y, Boon WC, Jones ME, Britt KL, and Simpson ER. Cellular and molecular characterization of the adipose phenotype of the aromatase-deficient mouse. Endocrinology 144: 1474-1480, 2003.
25. Morrison TB, Weis JJ, and Wittwer CT. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 24: 954-962, 1998.
26. Nelson BA, Robinson KA, and Buse MG. High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes. Diabetes 49: 981-991, 2000.
27. Obici S, Wang J, Chowdury R, Feng Z, Siddhanta U, Morgan K, and Rossetti L. Identification of a biochemical link between energy intake and energy expenditure. J Clin Invest 109: 1599-1605, 2002.
28. Parker GJ, Lund KC, Taylor RP, and McClain DA. Insulin resistance of glycogen synthase mediated by o-linked N-acetylglucosamine. J Biol Chem 278: 10022-10027, 2003.
29. Pedersen O, Kahn CR, Flier JS, and Kahn BB. High fat feeding causes insulin resistance and a marked decrease in the expression of glucose transporters (Glut 4) in fat cells of rats. Endocrinology 129: 771-777, 1991.
30. Pedersen O, Kahn CR, and Kahn BB. Divergent regulation of the Glut 1 and Glut 4 glucose transporters in isolated adipocytes from Zucker rats. J Clin Invest 89: 1964-1973, 1992.
31. Rossetti L. Perspective: hexosamines and nutrient sensing. Endocrinology 141: 1922-1925, 2000.
32. Rozen S and Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386, 2000.
33. Rumberger JM, Wu T, Hering MA, and Marshall S. Role of hexosamine biosynthesis in glucose-mediated up-regulation of lipogenic enzyme mRNA levels: effects of glucose, glutamine, and glucosamine on glycerophosphate dehydrogenase, fatty acid synthase, and acetyl-CoA carboxylase mRNA levels. J Biol Chem 278: 28547-28552, 2003.
34. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, and O'Rahilly S. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 50: 2199-2202, 2001.
35. Shafi R, Iyer SP, Ellies LG, O'Donnell N, Marek KW, Chui D, Hart GW, and Marth JD. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc Natl Acad Sci USA 97: 5735-5739, 2000.
36. Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, and Kahn BB. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem 268: 22243-22246, 1993.
37. Tang J, Neidigh JL, Cooksey RC, and McClain DA. Transgenic mice with increased hexosamine flux specifically targeted to beta-cells exhibit hyperinsulinemia and peripheral insulin resistance. Diabetes 49: 1492-1499, 2000.
38. Thomson MJ, Williams MG, and Frost SC. Development of insulin resistance in 3T3-L1 adipocytes. J Biol Chem 272: 7759-7764, 1997.
39. Tozzo E, Shepherd PR, Gnudi L, and Kahn BB. Transgenic GLUT-4 overexpression in fat enhances glucose metabolism: preferential effect on fatty acid synthesis. Am J Physiol Endocrinol Melab 268: E956-E964, 1995.
40. Veerababu G, Tang J, Hoffman RT, Daniels MC, Hebert LF Jr, Crook ED, Cooksey RC, and McClain DA. Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance. Diabetes 49: 2070-2078, 2000.
41. Vosseller K, Wells L, Lane MD, and Hart GW. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 99: 5313-5318, 2002.
42. Wang J, Liu R, Hawkins M, Barzilai N, and Rossetti L. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 393: 684-688, 1998.
43. Yang X, Zhang F, and Kudlow JE. Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3 A: coupling protein O-GlcN Acylation to transcriptional repression. Cell 110: 69-80, 2002.
44. Yki-Jarvinen H, Virkamaki A, Daniels MC, McClain D, and Gottschalk WK. Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo. Metabolism 47: 449-455, 1998.
45. Zhou J, Neidigh JL, Espinosa R, 3rd LeBeau MM, and McClain DA. Human glutamine: fructose-6-phosphate amidotransferase: characterization of mRNA and chromosomal assignment to 2p13. Hum Genet 96: 99-101, 1995.